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Summary We examined the relationship between p53 levels before and after irradiation, radiation-induced cell
cycle delays, apoptotic cell death and radiosensitivity in a panel of eight human tumour cell lines. The cell lines
differed widely in their clonogenic survival after radiation, (surviving fraction at 2 Gy: SF2 =0.18-0.82).
Constitutive p53 protein levels varied from 2.2+0.4 to 6.3+0.3 optical density units (OD) per 106 cells. p53
after irradiation (6 Gy) also varied between the cell lines, ranging from no induction to a 1.6-fold increase in
p53 levels 4 h after treatment. p53 function was also assessed by GI cell cycle arrest after irradiation. The
cellular response to radiation, measured as GO/GI arrest, and the induction of apoptosis were in good
agreement. However, a trace amount of DNA ladder formation was found in two cell lines lacking GI arrest.
Overall cellular radiosensitivity correlated well with the level of radiation-induced GI arrest (correlation
coefficient r=0.856; P=0.0067), with p53 constitutive levels (r=0.874, P=0.0046), and with p53 protein fold
induction (r= -0.882, P=0.0038). Our data suggest that (1) the constitutive p53 level, (2) GI arrest after
irradiation, or (3) the p53 protein response to radiation may be good predictive tests for radiosensitivity in
some cell types.
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It is generally accepted that ionising radiation kills eukaryotic
cells by damaging the structure and function of genomic
DNA. Much effort has consequently been focused on
understanding how cells respond to DNA damage and
restore the DNA sequence integrity and chromatin struc-
ture. Differences in the intrinsic radiosensitivity of human
cells are now acknowledged, and the picture that emerges
from the review of radiobiological data suggests that these
differences may be related to: (a) the number of initial
radiation-induced DNA double-strand breaks (dsbs) (Ruiz de
Almodovar et al., 1994); (b) the number of unrejoined DNA
dsbs (Wurm et al., 1995); (c) the rate of rejoining of dsbs
(Nuniiez et al., 1995; Whitaker et al., 1995) and (d) the fidelity
of dsb rejoining (Powell and McMillan, 1994).
It has also been suggested that transient alterations in cell
cycle progression in GI and G2 phases after exposure to
different DNA-damaging agents are important components
of the cellular response to DNA damage (Kastan et al., 1992;
Canman et al., 1994; Baker et al., 1990). These alterations
presumably permit optimal repair by delaying DNA
replication (GI arrest) (Kastan et al., 1992) and chromosome
segregation (G2 arrest) (Nagasawa et al., 1994).
The function of p53 appears to form part of a negative
regulator pathway of DNA synthesis leading to GI arrest
after cellular exposure to DNA-damaging agents, since there
is a close temporal association between the post-transcrip-
tional increase in p53 protein levels and G1 arrest after
irradiation (Kastan et al., 1991). In contrast, cells with
mutant p53 genes or lacking p53 genes failed to show any
increase in p53 protein after DNA damage; this correlates
with a lack of GI arrest (Kastan et al., 1991; Kuerbitz et al.,
1992), although these cells still show G2 arrest. Stewart et al.
(1995) recently suggested that the antiproliferative activity of
p53 may be also involved in the G2/M restriction point.
Many studies have shown that most p53 mutations result
in a non-functional protein that accumulates in tumour cells
(Levine et al., 1991; Hollstein et al., 1991). It seems that p53
protein accumulation is a consequence of its stabilisation
(Hall et al., 1991; Schlichtholz et al., 1992). Loss of p53
function as in mutant p53 was recently shown to increase the
resistance to DNA-damaging agents in human tumour cell
lines (McIlwrath et al., 1994; Fan et al., 1994). High
constitutive levels of intracellular p53 levels may thus be
related with radioresistance to ionising radiation; the relation
between the cellular response to radiation-induced damage
(G1 block) and the triggering of apoptotic cell death may
explain the differences in radiosensitivity.
To investigate this hypothesis we have used a panel of
eight human tumour cell lines that differed widely in their
clonogenic survival after radiation. We developed an
immunoenzyme assay to measure constitutive p53 protein
levels in whole human tumour cells attached to the
monolayer. These data were compared with radiation-
induced apoptosis, with the intrinsic cellular radiosensitivity
values and with p53 functionality assessed through GQ arrest
and p53 induction.
Materials and methods
Cell culture, radiation treatment and clonogenic assay
Nine human tumour cell lines were studied, although one of
them, HL60, was only used as a negative control in a set of
experiments. Three different clones of the MCF-7 cell line
originally established by Soule et al. (1973) were obtained
from G Leclercq (Institut Jules Bordet, Brussels, Belgium),
from C Sonnenschein (Tufts University, Boston, MA, USA)
and from the American Type Culture Collection, named
herein respectively MCF-7 BB, MCF-7 BUS (Ruiz de
Almodovar et al., 1994) and MCF-7 GS. The EVSA-T
human breast cancer line (Lippman et al., 1976) was obtained
from G Leclercq (Institut Jules Bordet, Brussels, Belgium).
The clone of T47D human breast cancer cell line established
by Keydar et al. (1979) and named T47D-B8 (Soto et al.,
1986) was obtained from C Sonnenschein. Cell line MDA-
MB-231 was established by Cailleau et al. (1974). The RT-
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112 human bladder carcinoma cell line (Masters et al., 1986)
was obtained from JRW Masters (The Institute of Urology,
London, UK). Human medulloblastoma cell line D283MED
(Friedman et al., 1985) and myeloid leukaemia cell line HL60
(Collins et al., 1977) were also used.
Cell cultures were grown in Dulbecco's modified Eagle
medium (DMEM, Gibco) supplemented with 10% fetal calf
serum (FCS) and incubated at 37°C in 95% air/5% carbon
dioxide.
Cells in the exponential growth phase were irradiated
using a cobalt-60 source at a dose rate of 1.67 Gy min-'. For
the flow cytometry experiments and for the p53 time course
expression after cellular irradiation, a single 6 Gy dose was
delivered. The radiation dose response for p53 induction was
studied for a dose range from 2 to 8 Gy. Cellular survival
after irradiation was assessed using acute-dose clonogenic
assays performed in monolayer cultures as previously
described (Ruiz de Almodovar et al., 1994; Nuiniez et al.,
1995). Survival data were fitted using the linear-quadratic
model [lnSF = -(aD +,3D2)], with non-linear regression
analysis. The values of survival fraction at 2 Gy (SF2)
obtained from these fits are given in Table I.
Flow cytometry
At various times after y-irradiation (6 Gy) ranging from 4 to
48 h, cell cycle analysis was done. After harvest, cells were
suspended in full culture medium, centrifuged at 1200 r.p.m.
for 3 min and stained with 1 ml Vindelov's solution
containing 7.5 x 10-5 M propidium iodide (PI) as described
previously (Robinson, 1993). The cells were then incubated at
4°C for 10 min before running on an Ortho Cyteron absolute
flow cytometer in which DNA content was used to
distinguish each cell cycle phase. Quantification of cells in
each cell cycle phase was done using the Ortho Cell Cycle
program provided by the manufacturer. The proportion of
cells in each cell cycle phase was expressed as a ratio of the
percentage in unirradiated cells.
p53 protein ELISA whole cell assay
We used an immunoenzyme assay to measure the level of p53
protein in whole cells. Briefly, cells in exponential growth
were harvested and counted, and appropriate numbers of
cells were seeded in 24-well plates (Falcon) 24 h before the
beginning of the assay in order to allow cells to attach to the
culture flasks. Cells were then fixed with cold methanol ace-
tone (1:1) for 10 min at 4°C, then rinsed with phosphate-
buffered saline (PBS) to remove fixatives. Dry plates were
stored until use. We added 150 pl of the polyclonal rabbit
antiserum anti-p53 antibody CM-1 (Lander) which recognises
conformational epitopes for both wild and mutant p53
proteins, diluted 1:1000 in 1% PBS with bovine albumin
(BSA-PBS) and incubated the cells for 2 h at 4°C. The
plates were then washed twice with 500 pl cold 1% BSA -
PBS for 10 min at 4°C. The washing solution was removed
and 150 pl of peroxidase-conjugated swine antiserum to the
rabbit immunoglubulin (M701, Dako) diluted 1:1000 was
added and the cells were incubated again for 2 h at 4°C.
After a washing step as above, bound enzyme activity was
detected with 200 ,ul of a 0.4 mg ml-' solution of ortho-
phenylenediamine (OPD) peroxidase substrate (Sigma Fast,
Sigma) according to the directions for use provided by the
manufacturer. Aliquots from each well were transferred to
wells in a 96-well microtitre plate, and results were monitored
at 492 nm in an automatic-plate reader (Titertek Multiskan
plus, ICN Flow). This method allowed us to assess optical
density values (corresponding to the p53 protein content in
cells) ranging from 2.5 x 104 to 1.5 x 105 per well. The
number of cells per well was checked again after the
experiment was done.
p53 Western blotting assay
To measure p53 protein levels at different times after cell
irradiation, cell extracts were prepared by lysing cells in 1%
Nonidet P-40, 5% sodium deoxycholate and 0.1% sodium
dodecyl sulphate in the presence of protease inhibitors. Cell
extracts were stored at -80°C until use. Protein concentra-
tion was determined by the Bio-Rad protein assay, and 20 pg
of protein was loaded onto an SDS-polyacrylamide gel. The
gels were run at 150 V for 90 min in a Bio-Rad mini gel
system. Proteins in the gel were transferred to a nitrocellulose
membrane (100 V, 1 h) and then blocked for 1 h in 5% non-
fat milk at room temperature. A polyclonal antibody to p53
(CM-1, Lander) was used for p53 protein determinations.
Antibody reaction was revealed with chemiluminescence
detection procedures according to the manufacturer's
recommendations (ECL kit, Amersham).
Assay for DNA fragmentation
At the end of each incubation period after radiation, floating
and adherent cells were centrifuged for 10 min at 900 g and
washed with PBS. The pellet was resuspended in a lysis buffer
(100 mm Tris-HCl pH 8, 10 mM EDTA, 10 mm sodium
chloride, 2% SDS and 10 pl of a 10 mg ml-' solution of
RNAase), and incubated at 37°C for 30 min. We then added
100 pg ml-' protein kinase and incubated the mixture at 370C
overnight. The DNA was extracted by phenol and chlor-
ophorm-iso-amyl alcohol (24:1), precipitated overnight in
-20°C ethanol containing sodium acetate at a final
concentration of 0.3 M, centrifuged for 10 min, 4°C, at high
speed (Microfuge, Beckman). The pellet was resuspended in
Tris-EDTA buffer (0.1 M Tris-HCl, pH 8, 10 mM EDTA).
The DNA samples (0.2 pg each) were electrophoretically
separated on a 1% agarose gel containing ethidium bromide
(0.5 pg ml-1). DNA was visualised with an UV trans-
illuminator, and the gels were photographed with a Polaroid
camera.
Table I Cell lines, radiosensitivity, cell cycle arrest and constitutive levels of p53
Cell line Origina SF2 GI arrestb G2 arrestc p53d Foldp53e p53 statul Apoptosisg
MCF-7 BUS 1 0.33±0.04 1.53 2.41 2.31±0.23 1.56 wt (+)
MCF-7 BB 1 0.50+0.02 1.25 1.70 3.67+0.48 1.14 mt (-)
MCF-7 GS 1 0.28+0.03 1.66 2.39 3.26+0.27 1.37 wt (+)
T47D-B8 1 0.55+ 0.01 1.33 1.37 3.64+0.31 1.16 mt
EVSA-T 1 0.65+0.03 1.08 2.45 3.38+ 0.45 0.90 mt (+ /
MDA-MB-231 1 0.82+0.02 1.07 2.76 6.30+0.28 1.07 mt (-)
RT-112 2 0.68+0.02 1.00 2.20 4.65+0.29 1.01 mt (+/-)
D283MED 3 0.18±0.01 1.42 1.86 2.08+0.24 1.38 wt (+)
HL60 4 - - - 0.00±0.00 -
al, Breast cancer cell line; 2, bladder carcinoma cell line; 3, medulloblastoma cell line; 4, myeloid leukaemia cell line. b Maximum ratio ofcells in
G1 after irradiation compared to unirradiated cells. c Maximum ratio ofcells in G2 after irradiation compared to unirradiated cells. d p53 optical
density units x 106cells measured in untreated cells: constitutive levels ofp53; e p53-fold inductionmeasured 4 h aftercell irradiation. fwt, wild-type
p53; mt, mutant-type p53. g (+), clear appearence of oligonucleosomal fragments; (+/-), trace amount of DNA ladder formation; (-), smear
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Results
Clonogenic cell survival assay
Table I shows the acute radiation dose-cell survival fraction
at 2 Gy for all the cell lines assayed. Experiments were
performed at least three times with each cell line, and pooled
data were fitted to a linear-quadratic equation to obtain these
estimates of the surviving fraction at 2 Gy. SF2 values ranged
from 0.18 to 0.82. Cell line D283MED (medulloblastoma)
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was the most radiosensitive and MDA-MB-231 breast cancer
cells were the most radioresistant.
Radiation-induced cell cycle arrest
In mammalian cells, exposure to radiation is known to induce
both GI and G2 arrests. After irradiation, time course
experiments of cell cycle distribution were done. The growth
arrest in GO/GI and in G2/M as determined by PI staining
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Figure 1 Time course of Go/GI ratio for irradiated (6Gy) vs unirradiated cells, assessed by flow cytometry. Points represent means of at
least three experiments; a minimum of 10000 events were counted.
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and DNA flow cytometry are shown in Figures 1 and 2. The
maximum values obtained (Table I) allowed us to assess
whether the p53 protein was functional. In spite of the
limitations of PI staining, this method is widely used (Fan et
al., 1994; O'Connor et al., 1993; Strasser et al., 1994), and the
patterns of radiation-induced cell cycle arrest that we
obtained were similar to the published analyses of cell cycle
delays. Based on linear regression analysis, we found no
relationship between the degree of G2 and G1 arrests
(r=-0.146, P=0.730), and conclude that the two blocks
0
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._
are independent events that can be assessed by PI staining.
We found two different trends in the cell lines studied. Some
cells were arrested in G1, and we presume that they probably
had wild-type p53 (Kastan et al., 1991). In fact, they have
low endogenous p53 levels, which may be an indirect
indication of p53 functionality. Cell lines MCF-7 BUS,
MCF-7 GS and D283MED may also belong to this group. In
contrast the rest of the cell lines (MCF-7 BB, T47D, MDA-
MB-231 EVSA-T and RT-112) were arrested in G2 but not in
G1, and probably correspond to cells with non-functional
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Figure 2 Time course of G2/M ratio for irradiated (6Gy) vs unirradiated cells, assessed by flow cytometry. Points represents means of at
least three experiments; a minimum of 10000 events were counted.
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p53. This may correlate with the higher p53 levels observed in
these lines (Kastan et al., 1991). Cell line MCF-7 has wild-
type p53 (Takahashi and Suzuki, 1993), whereas T47D and
MDA-MB-231 have mutant p53 (Bartek et al., 1990).
We found a close relationship between intrinsic cellular
radiosensitivity and the degree of G, arrest observed
(r=-0.869, P=0.0051). In contrast, our data do not
support the relationship between G2 arrest and radio-
sensitivity (Figure 3).
P53 protein ELISA whole cell assay
The relationship between optical density (OD) measured at
492 nm and cell number was linear in all experiments. The P-
values of this relationship were always highly significant
(P<0.0001). When the p53 values in OD units were plotted
on the y-axes vs cell number, the straight lines corresponding
to each cell line differed widely in their slope (Figure 4, Table
I). Each experiment was done at least three times, and the
results obtained suggest that the assay was highly reprodu-
cible. Background levels of OPD staining were typically
about 0.065 OD units. Corresponding background values
were subtracted in each experiment.
To validate the ELISA whole cell assay we used HL-60
myeloid leukaemia cells, which lack endogenous p53 genes
(Kuerbitz et al., 1992). In this experiment the values of p53
OD were independent of cell number, and did not show any
differences between the values for signal or noise
(slope=0.00, Table I). Overall we found a close relationship
between the constitutive levels of p53 and the SF2 values
(r=0.874, P=0.0046, Figure Sa) in the panel of cell lines
used. Cells with the highest slopes were the most radio-
a
1.0
0.8 U
resistant, whereas lower slope values corresponded to
radiosensitive cells. The high levels of p53 in radioresistant
lines may be an indirect indication that these lines contain
non-functional p53 protein.
Time course ofp53 induction
We determined intracellular p53 levels at different times after
cellular irradiation. There were two extreme patterns of
response: (1) in lines MCF-7 BUS, MCF-7 GS and
D283MED, there is an initial increase in p53 intracellular
levels, which reached maximum values 4 h after irradiation;
(2) in lines MCF-7 BB, T47D, EVSA-T, MDA-MB-231 and
RT-112, p53 showed little or no response of p53 to DNA
damage induced by radiation. Figure 6a shows an example
from each group.
These time course patterns were confirmed by p53 Western
blotting assays (Figure 7). We chose 4 h after cell irradiation
as a reference point to study the p53 response to different
doses of radiation. These experiments revealed differences
between the cell lines that seemed to correlate with one or
other of the patterns described above (Figure 6b). The mean
values of p53 fold induction 4 h after treatment are shown in
Table I. Interestingly, there was a close relationship between
the level of p53 fold induction and both intrinsic cellular
radiosensitivity (SF2), (r=0.882, P=0.0038, Figure Sb) and
the degree of G1 arrest (r=0.889, P=0.0032, Figure Sc).
Apoptotic response to y-radiation
Chromatin cleavage appears to be the most characteristic
biochemical feature of the apoptotic process. The appearance
of the ladder of nucleosomal DNA fragments in agarose gels
is thus the hallmark of apoptosis. We assessed apoptosis 24
and 48 h after treatment with 6 Gy, and assigned one of
three possible scores to each cell line (Figure 8, Table I).
MCF-7 BUS, MCF-7 GS and D283MED were classified as
positive (class +: clear appearance of oligonucleosomal
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Figure 3 Radiation-induced cell cycle arrest and radiosensitivity.
(a) Surviving fraction at 2Gy and maximal degree of GI arrest
(24-30h), r= -0.869, P=0.0051. (b) Surviving fraction at 2Gy
and maximal degree of G2 arrest (12-18h), r=0.284, P=0.495.
The percentage of cells was referred to the values in the controls
and expressed as the relative proportion of cells in GI and G2.
Points are means of at least three experiments + s.e.m.
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Figure 4 Immunoenzyme assay to quantify p53 levels in MDA-
MB-231 (-) and MCF-7 BUS (v) cell lines. Cells were plated at
densities of 25000-150000 cells per well and optical densities
(OD) were measured in a plate reader at 492nm. Points are
means of at least three experiments + s.e.m.
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fragments); lines RT-112 and EVSA-T showed a trace
amount of DNA ladder formation (class +); and lines
MDA-MB-231, MCF-7 BB and T47D were negative (class
-, smear pattern).
a b
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p53 constitutive levels
b
4 8 12 16 20 24 2 4 6 8
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Figure 6 (a) Time-course of p53 response to irradiation. (b) p53
response 4h after cell treatment with different doses of radiation.
Each point represents the mean of two independent experiments
performed by quadruplicate + s.e.m. MCF-7 BUS (C) and
MDA-MB-231 (O).
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Figure 5 (a) Relationship between constitutive levels of p53 and
surviving fraction at 2Gy, r=0.874, P=0.0046. (b) Relationship
between fold induction of p53 4 h after cell treatment with y-rays
and surviving fraction at 2Gy, r = -0.882, P = 0.0038. (c)
Relationship between fold induction of p53 4h after cell
treatment with y-rays and degree of G1 arrest, r =0.889,
P=0.0032. Points are means of at least three experiments +
s.e.m.
Figure 7 (a) Levels of p53 protein measured by Western blotting
at various times after ionising radiation. (b) Relative intensity of
different bands quantified by image analysis in D283MED (0)
and RT-112 (0).
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Figure 8 DNA analysis by 1% agarose gel electrophoresis of
genomic DNA extracted from D283MED (+, clear appearance
of oligonucleosomal fragments), EVSA-T (+ trace amount of
DNA ladder formation) and MCF-7 BB (-, smear pattern) 48 h
after irradiation.
Discussion
It has been realised for some time that human tumour cell
lines can differ widely in their survival characteristics after
treatment with ionising radiation. The data presented here
are representative of the range of radiosensitivities (0.18-
0.82) commonly seen in human tumour cell lines. Studies of
DNA removed from cells immediately after irradiation reveal
extensive damage, and it is generally accepted that ionising
radiation kills eukaryotic cells by damaging the structure and
function of genomic DNA. Recent evidence suggests that
DNA damage causes transient alterations in cell cycle
progression via both G1 and G2 arrests (Kastan et al.,
1991). Differences in cell cycle arrests have been shown to be
associated with quantifiable differences in cellular radio-
sensitivity (Kastan et al., 1991, 1992; Canman et al., 1994;
Kuerbitz et al., 1992; Mcllwrath et al., 1994; Fan et al., 1994;
O'Connor et al., 1993; Nagasawa et al., 1994). Until recently
the association of prolonged cell cycle delays with radio-
resistance was interpreted as a means by which the cell is
given increased time to repair DNA damage (Kastan et al.,
1991). It is now recognised that p53 plays a key role in the
G,/S transition through its transactivation of WAFI/Cipl,
which inhibits G, cyclin-dependent kinases (Harper et al.,
1993; El-Deiry et al., 1993).
Studies of p53 have suggested that the above interpreta-
tion of the importance of the post irradiation checkpoints
may be inadequate. It was recently suggested that p53 protein
is involved in DNA damage recognition and apoptosis
initiation. Thus p53 gene status and cellular radiosensitivity
might be connected. Mutant p53 has been shown to decrease
the radiation-induced G1 arrest but to increase radio-
resistance (McIlwrath et al., 1994; Fan et al., 1994;
O'Connor et al., 1993). This has been explained in some
systems by the requirement for functional p53 to be present
for apoptosis to occur (Lowe et al., 1993; Merritt et al.,
1994), but it is not clear whether this is always the route by
which p53 alters radiosensitivity. Xia (1995) has recently
reported a correlation between altered p53 status, high p53
constitutive levels, reduced increase in p53 levels after
irradiation and radioresistance in two lymphocyte lines, but
there was no difference in the overall degree of apoptosis.
The possible relationship between p53 mutation and
radiosensitivity has obvious implications for radiotherapy
(Lowe et al., 1994; Levine et al., 1994), because of the high
incidence of p53 mutations in human cancers. This is the
issue that the present study was designed to address. A study
by McIlwrath et al. (1994) suggested that there are two
groups of tumour cell lines, based on p53 function assessed
by p53 induction by radiation and suppression of DNA
synthesis. The data presented here confirm this finding in a
different set of human tumour cell lines, and document a
close overall correlation between radiosensitivity, constitutive
p53 levels, the degree of p53 induction and modifications in
the cell cycle G1 checkpoint. Although a correlation is not
proof of a cause, the relationship seen here is close enough to
strongly imply that p53 function is an important determinant
of radiosensitivity.
To date, we have investigated apoptosis (by DNA
fragmentation assay) in all cell lines tested here, and have
found a close relationship between the appearance of
oligonucleosomal fragments and GO/GI cell cycle arrest
(Table I). Moreover, a smear pattern or a trace amount of
DNA fragmentation are common findings in cells containing
non-functional p53. It has been proposed that p53-dependent
apoptosis is a cell type-specific phenomenon, and that the G2
checkpoint may also be important in determining radio-
sensitivity (Slichenmyer et al., 1993). In this connection,
although our results support the idea of the greater
importance of the G,/S boundary in relation to radio-
sensitivity, we cannot exclude a role for the G2/M checkpoint
as a determinant of the response in cells that do not show Go/
GI arrest. In fact, although loss of wild type p53 may
abrogate GI arrest, radiation-induced apoptosis can still
occur in human tumour cell lines through a mechanism
independent of p53 (Bracey et al., 1995). We found a weak
ladder pattern in RT-112 and EVSA-T cells, both of which
show no GI arrest. To elucidate the importance of apoptosis
for intrinsic cellular radiosensitivity apoptosis must be
studied quantitatively. We have investigated apoptosis in
cell line D283MED (Ung et al., in preparation), and have
found that despite its apparently normal p53 response,
apoptosis occurs in a minority of cells even after a dose
that reduces survival to 0.001. Thus, although apoptosis may
be a factor in some of the cell lines described here, it appears
unlikely to be the only explanation for the high sensitivity of
cells with an apparently intact p53 system.
In conclusion, the use of different tests based on (1) the
presence offunctional GI arrest after cell treatment (Figure 3a);
(2) the quantitative measurement of constitutive levels of p53
protein in the tumour cells (Figure Sa); and (3) the increase in
intracellular p53 levels after DNA radiation-induced damage
(Figure Sb), could offer a solution to the problem of the
assessment ofintrinsic radiosensitivity as a predictor ofpatient
response to radiotherapy. However, further evidence in support
of this hypothesis may well come from studies of the roles of
p53, cell cycle control mechanisms and the relative importance
of apoptosis and mitotic cell death after irradiation, which are
now being pursued at our laboratory.
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